{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-274071","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.176491+00:00","generated_at":"2026-06-08T08:17:25.301598+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HCA targets 4-6% EBITDA, 8-12% EPS growth over 5 yrs; 2024 within ranges","bullets":["Adjusted EBITDA growth target of 4% to 6% annually over next five years.","Diluted EPS growth target of 8% to 12% annually over next five years.","2024 expectations fall within those ranges, after resolving Q1 commercial payer dispute.","More detailed 2024 guidance to be provided in January year-end call."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-274071","json":"https://secwatch.observer/filing/0001193125-23-274071.json","markdown":"https://secwatch.observer/filing/0001193125-23-274071.md","text":"https://secwatch.observer/filing/0001193125-23-274071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312523274071/0001193125-23-274071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312523274071/d263099d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T08:17:25.301598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}